The 170-kDa subunit of the galactoseadherence lectin (Gal-lectin) ofEntamoeba histolytica mediates adherence to human colonic mucins and intestinal epithelium as a prerequisite to amebic invasion. The Gal-lectin is an immunodominant molecule and a protective antigen in the gerbil model of amebiasis. Tumor necrosis factor a (TNF-a) produced by activated macrophages enhances nitric oxidedependent cytotoxicity in host defense against E. histolytica. The purpose of this study was to identify the Gal-lectin epitopes which stimulate TNF-a production by macrophages. Murine bone marrow-derived macrophages (BMMs) exposed to Gal-lectin (100-500 ng/ml) stimulated stable expression of TNF-a mRNA (8-fold increase) and TNF-a production similar to that of lipopolysaccharide-stimulated cells (100 ng/ml).Polyclonal anti-lectin serum specifically inhibited TNF-a mRNA induction in response to the Gal-lectin but not to lipopolysav.charide. Anti-lectin monoclonal antibodies 8C12, H85 and 1G7, which recognize nonoverlapping epitopes of the cysteine-rich region of the 170-kDa heavy subunit, inhibited both amebic adherence to mammalian cells and Gal-lectinstimulated TNF-ca mRNA expression by BMMs, but monoclonal antibody 7F4 did neither. As these inhibitory antibodies map to amino acids 596-1082 of the 170-kIDa Gal-lectin, our results have identified the functional region that mediates amebic adherence and TNF-ca mRNA induction in BMMs; thus, this region of the Gal-lectin is a subunit vaccine candidate.